Posters: CSV2024: 5th Symposium of the Canadian Society for Virology

Monday, June 3
Tuesday, June 4

Name	Job Title/Position	Organization	Abstract Title	Abstract Category	Poster #
Mr. Corby Fink	Postdoctoral Fellow	Robarts Research Institute, Western University	Nef inhibitors as adjuvants towards a cure for HIV/AIDS	Vaccines and Antivirals	034
Mrs Ghada Elfayres	Graduate Student	Universite de quebec a trois rivieres	Cellular platforms for the generation of SARS-CoV-2 VLPs and propagation- incompetent infectious vectors	Vaccines and Antivirals	039
Mr. Michael D'Souza	Graduate Student	University of Lethbridge	CRISPR-RfxCas13d-Mediated Antiviral Therapeutic Against Venezuelan Equine Encephalitis Virus RNA-Dependent RNA-Polymerase	Vaccines and Antivirals	036
Ms Simmone D'souza	Graduate Student	University of Calgary	A humanized single domain antibody can be used to target the hepatitis B virus covalently closed circular DNA genome	Vaccines and Antivirals	019
Dominique Daniels	Graduate Student	Wilfrid Laurier University	Special Delivery: Extracellular vesicles as carriers for long dsRNA and stimulation of the innate antiviral immune response against HCoV-229E	Vaccines and Antivirals	026
Mr. Michael D'Agostino	Graduate Student	McMaster University	Respiratory Mucosal Delivery of DNA Aptamer Nanomaterials as an Effective Anti-Infective Countermeasure Against SARS-CoV-2	Vaccines and Antivirals	035
Miss Júlia Cearto	Graduate Student	University of Manitoba	Pharmacological disruption of the necroptotic protein RIPK3 impairs respiratory syncytial virus (RSV) infection	Vaccines and Antivirals	030
Mr Jack Case	Undergraduate	Dalhousie University	Effect of influenza A virus mutations that confer baloxavir acid resistance on PA-X host shutoff	Vaccines and Antivirals	032
Miss Justine Beghin	Graduate Student	University of Alberta	Hepatitis Delta Virus (HDV): A potential Hepatitis B Virus (HBV) peptidomimetic therapeutic?	Vaccines and Antivirals	031
Lauren Aubrey	Graduate Student	University of Saskatchewan, VIDO	Evaluating the effect of maternal immunity on piglet immune response to H1N2 influenza vaccine	Vaccines and Antivirals	029
Akarin Asavajaru	Research Technician	VIDO (University of Saskatchewan)	Efficacy of a stable multivalent broadly protective subunit vaccine platform against SARS-CoV-2 variants of concern	Vaccines and Antivirals	025
Maia Finch	Graduate Student	University of Alberta	Assessing the impact of reovirus-neutralizing antibodies on reovirus oncolysis during oncolytic therapy	Putting Viruses to Work	021
Ms. Razieh Sadat Banijamali	Graduate Student	University of British Columbia	Mesenchymal stem cell-derived extracellular vesicles: a new strategy for delivering oncolytic coxsackievirus B3 in breast cancer treatment	Putting Viruses to Work	022
sanaz Ashraf-Nouhegar	Undergraduate	University of British Columbia	Understanding the Role of Coxsackievirus B3 in the Landscape of Immunogenic Proteins in Breast Cancer	Putting Viruses to Work	023
PhD Miguel Garcia-Leon	Research Assistant	National Autonomous University of Mexico	Prevalence of Gastrointestinal Pathogens in Children Under 15 Years in 28 States of Mexico	One Health	018
Miss Christina Frederick	Graduate Student	University of Manitoba	Monkeypox Virus (MPXV) Surveillance in Endemic and Non-Endemic Regions of East Africa at a One Health Animal-Human Interface	One Health	017
Kuldeep Kaur	Graduate Student	University Of Alberta	In silico structure prediction and characterization of X protein in human, woodchuck and duck: Insights into HBV associated HCC	Fundamental virology	011
Hannah Hauch	Graduate Student	University of British Columbia	Investigating Multimerization of the Zika Virus NS2A Protein	Fundamental virology	010
Madison Granoski	Graduate Student	University of Alberta	Respiratory Syncytial Virus Co-Infection Enhances Human Parainfluenza Virus Type 3 Infection	Fundamental virology	012
Ms. Claire Fernandes	Graduate Student	University of Toronto	Expanding a Virologist’s Toolbox: New Advances in Flow Virometry and Virus Sorting	Fundamental virology	014
Dr. Brett Duguay	Postdoctoral Fellow	Dalhousie University	Generation of infectious HCoV-OC43 recombinant viruses using a yeast reverse genetics platform	Fundamental virology	008
Faryal Dar	Graduate Student	School of Public Health, University of Saskatchewan/ Vaccine and infectious disease Organization	Proteolytic Cleavage of Bovine adenovirus-3 protein IIIa.	Fundamental virology	009
Deepa Chaphekar	Graduate Student	University of Toronto, Scarborough	A unique flow virometry screen identifies CD38 on the HIV-1 surface	Fundamental virology	007
Mr. Quinn Abram	Graduate Student	McGill University	Structural and functional analyses of the Flavivirus negative-strand intermediate	Fundamental virology	013
Ms. Marin Habbick	Graduate Student	University of Saskatchewan	The impact of sex in determining tolerance to pathogenic coronavirus infection	Emerging Viruses	005
Elise Gork	Graduate Student	University of Manitoba	Seroprevalence of Mpox in the Canadian Prairies Using Dried Blood Spots	Emerging Viruses	002
Carolina Camargo	Research Assistant	University of British Columbia	Towards the development of replicon models for negative-sense RNA viruses	Emerging Viruses	001
Mr. Arkadeb Bhuinya	Graduate Student	University of Saskatchewan	Evolution and role of Betacoronavirus Transcription Regulatory Sequence (TRS) in disease pathogenesis	Emerging Viruses	003
MS Nasim Akbari	Graduate Student	university of Saskatchewan	The role of human microproteins on Enterovirus-D68 virus life cycle	Emerging Viruses	004
Audray Fortin	Research Assistant	CRCHUM- Université de Montréal	Synergistic Inhibition of SARS-CoV-2 Replication: Exploring the Potential of Niclosamide, an Autophagy Inducing Drug, in Combination with Direct Antivirals	(not set)	092
Andrea Kroeker	(not set)	University of Saskatchewan	Adaptation of SARS-CoV-2 in ferrets alters tissue tropism leading to virus replication in the lungs	(not set)	043
Arely Hernández-Dávila	(not set)	University of Saskatchewan, Saskatoon	Myotis lucifugus Alphacoronavirus binds to bat and orthologous ACE2 receptors	(not set)	020
David Kelvin	(not set)	Dalhousie University, Halifax	Genome sequencing, annotation, and mutational profiling of a novel Mpox Clade I Subgroup VI virus causing a sustained Mpox outbreak in eastern DRC.	(not set)	006
Oluwaseyi Ajagbe	Graduate Student	Vaccine for Infectious Diseases and Department of Biochemistry, Microbiology and Immunology, University of Saskatchewan	Using Collaborative Cross Mice to Model Differential Mpox (Monkeypox) Disease Outcomes	Virus-host interactions	085
Mr. Nikolas Akkerman	Research Assistant	University of Manitoba	Wrestling with SUMOylation: Adenovirus E1A-induced SUMOylation of DREF promotes viral fitness through regulation of stress-response and adenoviral gene expression	Virus-host interactions	073
Josip Rudar	Graduate Student	Canadian Food Inspection Agency	Sequence signatures within the genome of SARS-CoV-2 can be used to predict host source	Virus-host interactions	059
Catherine Gong	Graduate Student	University of British Columbia	Identification of the proteolytic signature in CVB3-infected cells	Virus-host interactions	049
Mr. Spencer Luong	Undergraduate	University of Alberta	Wild reoviruses adapt to cell culture through improving uncoating-dependent and independent processes of replication.	Virus Evolution	047

Name	Job Title/Position	Organization	Abstract Title	Abstract Category	Poster #
Ms. Jessica Skoreyko	Graduate Student	University of Alberta	Repurposing compounds from the anti-cancer realm: using G-quadruplex binding agents to target Hepatitis B virus	Vaccines and Antivirals	127
Jessica Ramos	Graduate Student	University of Alberta	Characterization of a Vaccinia virus vectored COVID-19 vaccine expressing non-structural proteins	Vaccines and Antivirals	119
Mr Vahid Rajabali Zadeh	Postdoctoral Fellow	Vaccine and Infectious Disease Organization-University of Sasketchwan	Combination Therapy Enhances the Antiviral Activity of IFN-λ Against SARS-CoV-2 and MERS-CoV In Vitro	Vaccines and Antivirals	123
Mrs henintsoa rabezanahary	Research Assistant	CHUL	Efficacy of approved antiviral treatments against COVID-19 in immunosuppressed mice	Vaccines and Antivirals	125
Ms. Lianne Presley	Graduate Student	The University of British Columbia	Development and validation of a high-content image-based assay for the evaluation of lead compounds against human respiratory viruses with pandemic potential: influenza A virus, respiratory syncytial virus, and Omicron subvariant JN.1	Vaccines and Antivirals	128
Iliana Portelli	Graduate Student	Wilfrid Laurier University	Investigating the Role of the dsRNAi Pathway in Preventing Infection by Respiratory Syncytial Virus and Human Coronavirus in Human Lung Cells.	Vaccines and Antivirals	118
Mr. RICKY RAJ PASWAN	Graduate Student	University of Quebec Trois Rivieres	DENGUE VIRUS RESTRICTION BY CYTOPLASMIC TRIM PROTEINS	Vaccines and Antivirals	124
Dr. Ahmed Oraby	Postdoctoral Fellow	University of Alberta	Discovery of New Druggable Allosteric Sites in Viral Polymerase	Vaccines and Antivirals	116
Julien Miri	Graduate Student	Queen's University	Activation of interferon regulatory factor 1 by cyclosporine A does not contribute to its antiviral effect against dengue virus	Vaccines and Antivirals	121
Pauline McCluskie	Graduate Student	University of Ottawa	The Development and Characterization of Plant-Produced Nanoparticles for use in an Intranasal Vaccine Against Respiratory Viruses	Vaccines and Antivirals	130
Brielle Martens	Graduate Student	University of Manitoba	A population-based study of SARS-CoV-2 IgG antibody responses to vaccination in Manitoba	Vaccines and Antivirals	115
Mariam Maltseva	Graduate Student	University of Ottawa	Characterization of Heterologous Systemic Prime and Mucosal Boost Humoral Immune Responses to an SARS-CoV-2 Protein Subunit Vaccine Candidates in Mice	Vaccines and Antivirals	122
Arlo Loutan	Graduate Student	University of Alberta	Exploring metal-chelating compounds as cap-snatching endonuclease inhibitors of segmented negative-sense RNA viruses	Vaccines and Antivirals	114
Jocelyne Lew	Technician	VIDO	Development and Validation of Biolayer Interferometry Assay for Avidity-Testing of Antibodies Elicited Following SARS-CoV-2 Vaccination	Vaccines and Antivirals	120
Dr. Sam Workenhe	Principal Investigator	University of Guelph	Rewiring cancer cell death via oncolytic viruses generates potent anticancer immunity	Putting Viruses to Work	112
Dr. Karen Mossman	Principal Investigator	McMaster University	Inactive but not ineffective: therapeutic activity of non-replicating oncolytic herpesviruses	Putting Viruses to Work	111
Jason Knapp	Graduate Student	University of Guelph	Creating a heat-adapted vesicular stomatitis virus for improved oncolytic immunotherapy	Putting Viruses to Work	113
Mr. Sauhard Shrivastava	Graduate Student	VIDO, University of Saskatchewan	Discovering and Characterizing Bat Restriction Factors	One Health	110
Dr. Arianna Mahely Hurtado Monzon	Postdoctoral Fellow	Vaccine and Infectious Disease Organization, University of Saskatchewan	Assessing the wide range of animal susceptibility to SARS-CoV-2 variants of concern using a cell-based screening assay	One Health	109
Ethan Thomas	Graduate Student	Queen's University	The Multifunctional Viral Proteins pUL21 and pUL16 Facilitate Redundant Roles in Herpes Simplex Virus Type-1 (HSV-1) Nuclear Egress	Fundamental virology	101
Noga Sharlin	Graduate Student	University of Calgary	Human coronaviruses expand the functional repertoire of the nucleocapsid (N) protein by producing truncated N proteoforms	Fundamental virology	106
Mohaddeseh Pakzamir	Undergraduate	University of Alberta	Assessment of housekeeping gene expression in HBV infection	Fundamental virology	103
Qi Feng Lin	Graduate Student	University of Alberta	Naturally-circulating reoviruses are inefficient at intracellular uncoating and post-uncoating steps compared to prototypic lab-adapted reoviruses.	Fundamental virology	107
Mr Émile Lacasse	Graduate Student	Université Laval	In Yeast Assembly to Virus Rescue: An Efficient SARS-CoV-2 Reverse Genetic System.	Fundamental virology	104
Ronja Kothe	Graduate Student	University of British Columbia	Evaluating Protein-Protein Interactions in the Zika Virus Replicase Complex	Fundamental virology	108
Mr. Liam Kerr	Graduate Student	University of Lethbridge	The Circle of “Life”: Cyclization of Zika Virus genome occurs through sequence specificity	Fundamental virology	105
Laura Kellerer	Graduate Student	University of Saskatchewan	Testing Herpes Simplex Virus 1 (HSV1) transcription factor binding to Chromatin	Fundamental virology	102
Dr. Cynthia Swan	Research Technician	VIDO, University of Saskatchewan	Third dose of COVID-19 vaccines given to people living with high HIV viral load in Rwanda boosts antibody levels and cross-neutralization	Emerging Viruses	093
Mr Amirhossein Rooddehghan	Graduate Student	university of Saskatchewan, Vaccine and Infectious Disease Organization	Role of variant-specific SARS-CoV-2 non-structural accessory proteins in host-pathogen interactions	Emerging Viruses	096
Ms. Kristi Loeb	Graduate Student	University of Manitoba	Retrospective Orthopoxvirus Surveillance of female sex workers and gay, bisexual, and men who have sex with men populations in Nairobi, Kenya from 2013-2018	Emerging Viruses	098
Mr. Levi Klassen	Graduate Student	Public Health Agency of Canada	Disease modelling of clade I, IIa and IIb monkeypox virus isolates in Mus musculus castaneus and Peromyscus maniculatus rodents	Emerging Viruses	097
Dr. Rajesh Jacob	Research Associate	McMaster University	Detection of circulating autoantibodies and their association with SARS-CoV-2 disease progression	Emerging Viruses	094
Miss Michaella Jaba	Graduate Student	University of Manitoba	The Role of West African Chimpanzees in EBOV Circulation in Sierra Leone through Longitudinal Serosurveillance of semi-wild Chimpanzees at the Tacugama Chimpanzee Sanctuary	Emerging Viruses	095
PhD Miguel García-León	Research Assistant	National Autonomous University of Mexico	Prevalence of Respiratory Pathogens in Children with Pneumonia During the Second Half of the Pandemic in 6 Hospitals in Mexico	Emerging Viruses	100
PhD Miguel García-León	Research Assistant	Trabajo	Respiratory Viral and Bacterial Pathogens in Co-infection in Adults with COVID-19 During the Pandemic	Emerging Viruses	099
Agnitha Xavier	Graduate Student	University of Ottawa	Calmodulin activity is required for Ebolavirus entry	Virus-host interactions	141
Carly Lin	Undergraduate	The University of British Columbia	Viral proteins 3A and 3D synergistically mediate mitochondrial dysfunction in coxsackievirus B3-induced myocarditis.	Virus-host interactions	145
Manolya Sag	Graduate Student	University of British Columbia	Elucidating the switch from translation to replication in the HCV life cycle	Virus-host interactions	160
Ms. Aleksandra Stojic	Graduate Student	University of Alberta Faculty of Medicine and Dentistry	Respiratory Syncytial Virus Fusion Glycoprotein Adaptation and Community Circulation	Virus Evolution	140
Karyn Berry-Wynne	Research Technician	University of Alberta	RNA Viruses Hijack Nuclear Pore Components During Infection	Virus-host interactions	158

POSTERS

POSTERS